AmbioPharm

About

AmbioPharm is a global CDMO specializing in GMP-compliant peptide API manufacturing across early-stage, clinical, and commercial scales. With FDA-inspected facilities in the US (South Carolina) and China (Shanghai), they offer solid-phase, solution-phase, and hybrid peptide synthesis methods. Services include custom peptide and organic synthesis, microwave-assisted SPPS (via partnership with CEM), analytical development, and biologically active peptides with complex modifications. Their infrastructure supports high-capacity lyophilization, preparative HPLC, and batch sizes up to metric tons, enabling flexible production from grams to commercial volumes.

Services